BioXcel Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.03.25	BioXcel Therapeutics Stock Surges 105% On Positive FDA Update (RTTNews)
28.02.25	BioXcel Therapeutics Stock Surges 56% After Regaining Nasdaq Compliance (RTTNews)
06.02.25	BioXcel Therapeutics Sets 1-for-16 Reverse Stock Split To Regain Nasdaq Listing (RTTNews)
15.03.24	BioXcel Gets European Patent For Sublingual Dexmedetomidine To Treat Agitation In Dementia Patients (RTTNews)
13.02.24	BioXcel Therapeutics Terminates $60 Mln Proposed Public Offering (RTTNews)
12.02.24	BioXcel Therapeutics Announces FDA's Fast Track Designation For Investigation Of BXCL701 (RTTNews)
09.02.24	BioXcel Therapeutics Commences $60 Mln Public Offering; Stock Drops (RTTNews)
05.02.24	BioXcel: USPTO Allowed Patent Application For Method Of Treating Agitation In Alzheimer's Disease (RTTNews)
25.10.23	BioXcel Reports Positive Findings From Third Party Audit Of Data Integrity At Phase 3 Trial Site (RTTNews)
10.10.23	BioXcel Reports Positive OS Results From Phase 2 Trial Of BXCL701 In Patients With SCNC (RTTNews)
02.09.23	BTAI DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action - BTAI (PR Newswire)
26.08.23	ROSEN, LEADING INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action - BTAI (PR Newswire)
18.08.23	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
12.08.23	ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
05.08.23	ROSEN, LEADING TRIAL ATTORNEYS Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
28.07.23	ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
20.07.23	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
13.07.23	ROSEN, A LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAI (PR Newswire)
29.06.23	Pre-market Movers: SGTX, WAVE, BTAI, KTRA, CRMD… (RTTNews)
29.06.23	BioXcel Says TRANQUILITY II Phase 3 Study Of BXCL501 Met Its Primary Goal (RTTNews)
19.01.23	12 Biotech Stocks Hit New Highs; Did You Make The Most Of It? (RTTNews)
11.01.23	BioXcel Announces Promising Data From Phase 2 Trial Of BXCL701 Combination In Rare Prostate Cancer (RTTNews)
06.04.22	BioXcel Therapeutics : FDA Approves IGALMI Sublingual Film (RTTNews)
28.03.22	Biotech Stocks Facing FDA Decision In April 2022 (RTTNews)
01.12.21	Why BioXcel Therapeutics Stock Falling In Pre-market? (RTTNews)
15.11.21	Pre-market Movers: CREX, BTB, EYPT, OXBR, MICT… (RTTNews)
10.08.21	BioXcel Therapeutics Posts Wider-than-Expected Loss In Q2 (RTTNews)
21.07.20	AZN's COVID-19 Vaccine Shows Strong Responses, ACAD Fails CLARITY Study, BTAI Hits New High (RTTNews)
20.07.20	Stock Alert: BioXcel Therapeutics Up 30% (RTTNews)
20.06.20	Data Readouts Due This Month - Do You Have These Pharma Stocks In Your Portfolio? (RTTNews)
17.04.20	Revisiting BioXcel Therapeutics (BTAI) (RTTNews)
17.04.20	BTAI On Track To Report SERENITY Data, REGN Hits All-time High, THMO On Watch (RTTNews)
14.02.20	BioXcel Therapeutics' (BTAI) Journey From $7 To $41 In Less Than A Year (RTTNews)
13.02.20	Stock Alert: BioXcel Therapeutics (BTAI) (RTTNews)
06.02.20	BTAI Hits A High, TNXP's RECOVERY Fails, MRK Plans A Spin-off (RTTNews)
01.01.20	BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300% (RTTNews)
17.12.19	Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI (RTTNews)
08.03.19	This Day That Year: BioXcel Therapeutics (RTTNews)
04.01.19	BTAI Up 105% In 5 Days, NVAX Gets A Shot In The Arm, BMY Snaps Up CELG (RTTNews)
03.01.19	BioXcel Announces Positive Data On Senile Dementia Of Alzheimer's Type; Stock Up (RTTNews)
28.12.18	BTAI On Fast Track, ERYP Faces Busy Year Ahead, CHMA Turning Heads (RTTNews)
15.11.18	MNK Awaits D-Day, AMEH In Good Health, AXSM To Report ASCEND Data In Jan. (RTTNews)
24.09.18	BioXcel Expands Collaboration With Nektar To Initiate New Clinical Program (RTTNews)
11.07.18	INSP Soars On Aetna Coverage, BTAI On Track, VTL Awaits Data In Sep. (RTTNews)
04.05.18	LENS Back In Focus, NVTR Rides High, BTAI For The Long Haul, CHRS Resubmits BLA (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Kuehne+Nagel Int	218.50	4.70 %	K V
Swisscom	530.00	2.02 %	K V
Givaudan	4’061.00	1.50 %	K V
Zurich Insur Gr	602.00	1.21 %	K V
Geberit	586.00	1.03 %	K V
Part Grp Hldg	1’292.00	-2.45 %	K V
Logitech Intl	83.14	-2.60 %	K V
UBS Group	28.41	-3.60 %	K V
Lonza Grp	544.20	-3.75 %	K V
CieFinRichemont	158.45	-3.88 %	K V

Nachrichten zu BioXcel Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten